Belluscura plc (AIM: BELL)
London
· Delayed Price · Currency is GBP · Price in GBX 9.05
-0.20 (-2.16%)
Jan 17, 2025, 12:32 PM GMT+1
Belluscura Revenue
Belluscura had revenue of $1.35M USD in the half year ending June 30, 2024, with 139.57% growth. This brings the company's revenue in the last twelve months to $1.80M, up 50.09% year-over-year. In the year 2023, Belluscura had annual revenue of $825.41K, down -40.96%.
Revenue (ttm)
$1.80M
Revenue Growth
+50.09%
P/S Ratio
9.56
Revenue / Employee
$51.57K
Employees
35
Market Cap
15.58M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Belluscura News
- 5 months ago - Small Cap Stocks: Indus Gas, Futura Medical, Jersey Oil & Gas - The Armchair Trader